Suppression of noxious stimulus-evoked expression of fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist

Neuroscience

Volumn 70, Issue 3, 1996, Pages 791-798

  Tsou, K ^a   Lowitz, K A ^a   Hohmann, A G ^a   Martin, W J ^a   Hathaway, C B ^a   Bereiter, D A ^a   Walker, J M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

c fos; cannabis; pain

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABIS; FORMALDEHYDE; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ENANTIOMER; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; ONCOGENE C FOS; PAIN; PRIORITY JOURNAL; RAT; SPINAL CORD;

EID: 0030044427     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)83015-6     Document Type: Article

References (38)

1. Bloom A. S., Dewey W. L., Harris L. S. and Brosius K. K. (1977) 9-Nor-9β-hydroxyhexahydrocannabinol a cannabinoid with potent antinociceptive activity: comparisons with morphine. J. Pharmac. exp. Ther. 200, 263-270.
2. Bullit E. (1990) Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J. comp. Neurol. 296, 517-530.
3. 9-tetrahydrocannabinol in the rat and mouse. Psychopharmacologia 25, 275-280.
4. D'Ambra T. E., Estep K. G., Bell M. R., Eissenstat M. A., Josef K. A., Ward S. J., Haycock D. A., Baizman E. R., Caswiano F. M., Beglin N. C., Chippari S. M., Grego J. D., Kullning R. K. and Daley G. T. (1992) Conformationally restrained analogues of pravadoline:nanomolar potent, enantioselective, (ammo)indole agonists of the cannabinoid receptor. J. med. Chem. 35, 124-135.
5. Devane W. A. (1994) New dawn of cannabinoid pharmacology. Trends pharmac. Sci. 15, 40-41.
6. Devane W. A., Hanus L., Brener A., Pertwee R. G. Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A. and Mechoulam R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
7. Dewey W. L. (1986) Cannabinoid pharmacology. Pharmac. Rev. 38, 1-20.
8. Dubuisson D. and Dennis S. G. (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain 4, 161-174.
9. Fitzgerald M. (1990) C-fos and the changing face of pain. Trends Neurosci. 13, 430-440.
10. Giesler G. J. Jr, Menetrey D., Guilbaud G. and Besson J.-M. (1976) Lumbar cord neurons at the origin of the spinothalamic tract in the rat. Brain Res. 118, 320-324.
11. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., de Costa B. R. and Rice K. C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563-583.
12. Hohmann A. G., Martin W. J., Tsou K. and Walker J. M. (1995) Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sci. 56, 2111-2118.
13. Hollister L. E. (1986) Health aspects of cannabis. Pharmac. Rev. 38, 1-20.
14. Hsu S., Raine L. and Fanger H. (1981) Use of avidin-biotin-peroxidase complexes (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
15. Hunt S. P., Pini A. and Evan G. (1987) Induction of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. Nature 328, 632-634.
16. Jasmin L., Gogas K. R., Ahlgren S. C., Levine J. D. and Basbaum A. I. (1994) Walking evokes a distinctive pattern of Fos-like immunoreactivity in the caudal brainstem and spinal cord of the rat. Neuroscience 58, 275-286.
17. Kehle L. J., Gogas K. R., Lichtblau L., Pollock C. H., Mayes M., Basbaum A. I. and Wilcox G. L. (1991) The NMDA antagonist MK 801 reduces noxious stimulus-evoked FOS expression in the spinal cord dorsal horn. In Proc. VIth World Congress on Pain (eds Bond M. R., Charlton J. E. and Woolf C. J.), pp. 307-311. Elsevier, Amsterdam.
18. Kosersky D. S., Dewey W. L. and Harris L. S. (1973) Antipyretic, analgesic and anti-inflammatory effects of delta-9-tetrahydrocannabinol in the rat. Eur. J. Pharmac. 24, 1-7.
19. Lee J.-H. and Beitz A. J. (1992) Electroacupuncture modifies the expression of c-fos in the spinal cord induced by noxious stimulation. Brain Res. 577, 80-91.
20. Lichtman A. H. and Martin B. R. (1991) Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmac. exp. Ther. 258, 517-523.
21. Little P. J., Compton D. R., Johnson M. R., Melvin L. S. and Martin B. R. (1988) Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J. Pharmac. exp. Ther. 247, 1046-1051.
22. Lu J., Hathaway C. B. and Bereiter D. A. (1993) Adrenalectomy enhances Fos-like immunoreactivity within the spinal trigeminal nucleus induced by noxious thermal stimulation of the cornea. Neuroscience 54, 809-818.
23. Martin B. R., Compton D. R., Thomas B. F., Prescott W. R., Little P. J., Razdan R. K., Johnson M. R., Melvin L. S., Mechoulam R. and Ward S. J. (1991) Behavioral biochemical and molecular modeling evaluation of cannabinoid analogs. Pharmac. Biochem. Behav. 40, 471-478.
24. Martin W. J., Lai N. K., Patrick S. L., Tsou K. and Walker J. M. (1993) Antinociceptive actions of cannabinoids following intraventricular administration in rats. Brain Res. 629, 300-304.
25. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C. and Bonner T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
26. Mechoulam R., Devane W. A. and Glaser R. (1992) Cannabinoid geometry and biological activity. In Marijuana/ Cannabinoids. Neurobiology and Neurophysiology (eds Murphy L. and Bartke A.), pp. 1-33. CRC Press, Boca Raton, FL.
27. Moss D. E. and Johnson R. L. (1980) Tonic analgesic effects of delta-9-tetrahydrocannabinol as measured with the formalin test. Eur. J. Pharmac. 61, 313-315.
28. Pertovaara A., Bravo R. and Herdegen T. (1993) Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation. Neuroscience 54, 117-126.
29. Pertwee R. G. (1991) Tolerance to and dependence on psychotropic cannabinoids. In The Biological Bases of Drug Tolerance and Dependence (ed. Pratt J. A.), pp. 231-263. Academic Press, London.
30. Pertwee R. G. (1993) The evidence for the existence of cannabinoid receptors. Gen. Pharmac. 24, 811-824.
31. Pertwee R. G., Stevenson L. A. and Griffin G. (1993) Cross-tolerance between delta-9-tetrahydrocannabinol and cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Br. J. Pharmac. 110, 1483-1490.
32. Presley R. W., Menetrey D., Levine J. D. and Basbaum A. I. (1990) Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J. Neurosci. 10, 323-335.
33. Price D. D. (1988) Psychological and Neural Mechanisms of Pain, pp. 162-164. Raven Press, New York.
34. Smith P. B. and Martin B. R. (1992) Spinal mechanisms of delta-9-tetrahydrocannabinol-induced analgesia. Brain Res. 578, 8-12.
35. Sofia R. D., Nalepa S. D., Harakal J. J. and Vassar H. B. (1973) Anti-edema and analgesic properties of delta-9-tetrahydrocannabinol (THC). J. Pharmac. exp. Ther. 186, 646-655.
36. Tölle T., Castro-Lopes J. M., Coimbra A. and Zieglgänsberger W. (1990) Opiates modify induction of c-fos proto-oncogene in the spinal cord following noxious stimulation. Neurosci. Lett. 111, 46-51.
37. Willis W. D. Jr and Coggeshall R. E. (1991) Sensory Mechanism of the Spinal Cord, 2nd edn. Plenum Press, New York.
38. Yaksh T. L. (1981) The antinociceptive effects of intrathecally administered levoantradol and desacetyllevonantradol in the rat. J. clin. Pharmac. 21, 334S-340S.